
Yu Fujiwara
Assistant Professor · Medical College of Wisconsin Affiliated Hospitals, Inc
Credentials: · · ·
History
- 2017–2020
Research
Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy
Review · Cancer Treatment Reviews · 2022 · First of 7 authors · Corresponding · 266 citations
Review · Cancer Drug Resistance · 2020 · First of 4 authors · 72 citations
Systematic review or meta-analysis · The Lancet Oncology · 2024 · First of 8 authors · 65 citations

9 papers · 1 as a fellow

9 papers

8 papers

7 papers

7 papers · 2 as a fellow
- AK
5 papers · 5 as a fellow

5 papers

5 papers · 5 as a fellow


